CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and In Vitro Experiments

Figure 1

CYP26A1 was upregulated in PC and associated with worse clinical characteristics. Notes: (a) CYP26A1 was upregulated in PC tissue based on four paired PC and adjacent tissue. (b) CYP26A1 was upregulated in PC cell lines compared with normal cell line. (c, d) The protein level of CYP26A1 was upregulated in PC tissue and cell lines. (e) CYP26A1 was upregulated in PC tissue based on TCGA data. (f) CYP26A1 was overexpressed in the metastatic cell lines of PC compared with the primary cell lines. (g)–(l) The expression pattern of CYP26A1 in different groups.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)